Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Pulmongene Ltd.

Clinical trials sponsored by Pulmongene Ltd., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New kidney drug PMG1016 enters first human safety trial Results expected Nov 2026 (estimated)

Browse trials soon ready across all sponsors →

Not yet recruiting 1 Completed 1

Experimental drug PMG1015 tested for lung scarring disease

Disease control Completed

This early-phase trial tested an experimental drug called PMG1015 in 29 people with idiopathic pulmonary fibrosis (IPF), a lung-scarring disease. The main goal was to check the drug's safety and how the body processes it, not whether it works. Participants received either PMG1015…

Phase 1 • Sponsor: Pulmongene Ltd. • Aim: Disease control

Last updated Jun 27, 2026 07:59 UTC